1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Method Outlook
3.5. Application Outlook
3.6. End User Outlook
3.7. Geography Outlook
3.8. Competitor Outlook

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Viral Inactivation Market, by Method
6.1. Introduction
6.2. Pasteurization
6.3. Solvent Detergent Method

7. Viral Inactivation Market, by Product
7.1. Introduction
7.2. Kits & Reagents
7.3. Services
7.4. Viral Inactivation Systems & Accessories

8. Viral Inactivation Market, by Application
8.1. Introduction
8.2. Blood & Blood Product
8.3. Cellular & Gene Therapy Product
8.4. Stem Cell Product
8.5. Tissues & Tissue Product
8.6. Vaccines & Therapeutic

9. Viral Inactivation Market, by End User
9.1. Introduction
9.2. Academic Research Institutes
9.3. Contract Research Organizations
9.4. Pharmaceutical & Biotechnology Companies

10. Competitive Landscape
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitive Scenario
10.4.1. Merger & Acquisition
10.4.2. Agreement, Collaboration, & Partnership
10.4.3. New Product Launch & Enhancement
10.4.4. Investment & Funding
10.4.5. Award, Recognition, & Expansion

11. Company Usability Profiles

12. Appendix
12.1. Discussion Guide
12.2. License & Pricing
12.3. Contact Details

List of Figures

FIGURE 1. UNITED STATES VIRAL INACTIVATION MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2020 (USD MILLION)
FIGURE 4. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 6. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 7. UNITED STATES VIRAL INACTIVATION MARKET: MARKET DYNAMICS
FIGURE 8. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2020 VS 2026 (%)
FIGURE 9. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2020 VS 2026 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2026
FIGURE 11. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PASTEURIZATION, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PASTEURIZATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY SOLVENT DETERGENT METHOD, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY SOLVENT DETERGENT METHOD, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 16. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2026
FIGURE 18. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY KITS & REAGENTS, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY KITS & REAGENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY SERVICES, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY VIRAL INACTIVATION SYSTEMS & ACCESSORIES, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY VIRAL INACTIVATION SYSTEMS & ACCESSORIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 24. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 25. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2026
FIGURE 27. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY BLOOD & BLOOD PRODUCT, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY BLOOD & BLOOD PRODUCT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCT, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY STEM CELL PRODUCT, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY STEM CELL PRODUCT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY TISSUES & TISSUE PRODUCT, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY TISSUES & TISSUE PRODUCT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 35. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY VACCINES & THERAPEUTIC, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY VACCINES & THERAPEUTIC, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 37. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 38. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2026
FIGURE 40. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 41. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 42. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2026 (USD MILLION)
FIGURE 43. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 44. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2026 (USD MILLION)
FIGURE 45. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 46. UNITED STATES VIRAL INACTIVATION MARKET: FPNV POSITIONING MATRIX
FIGURE 47. UNITED STATES VIRAL INACTIVATION MARKET: MARKET SHARE ANALYSIS, BY QUADRANT
FIGURE 48. UNITED STATES VIRAL INACTIVATION MARKET: MARKET SHARE ANALYSIS, BY COMPANY
FIGURE 49. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES VIRAL INACTIVATION MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES VIRAL INACTIVATION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PASTEURIZATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY SOLVENT DETERGENT METHOD, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY KITS & REAGENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY VIRAL INACTIVATION SYSTEMS & ACCESSORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY BLOOD & BLOOD PRODUCT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY STEM CELL PRODUCT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY TISSUES & TISSUE PRODUCT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY VACCINES & THERAPEUTIC, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. UNITED STATES VIRAL INACTIVATION MARKET: SCORES
TABLE 21. UNITED STATES VIRAL INACTIVATION MARKET: BUSINESS STRATEGY
TABLE 22. UNITED STATES VIRAL INACTIVATION MARKET: PRODUCT SATISFACTION
TABLE 23. UNITED STATES VIRAL INACTIVATION MARKET: RANKING
TABLE 24. UNITED STATES VIRAL INACTIVATION MARKET: MERGER & ACQUISITION
TABLE 25. UNITED STATES VIRAL INACTIVATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 26. UNITED STATES VIRAL INACTIVATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 27. UNITED STATES VIRAL INACTIVATION MARKET: INVESTMENT & FUNDING
TABLE 28. UNITED STATES VIRAL INACTIVATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 29. UNITED STATES VIRAL INACTIVATION MARKET: LICENSE & PRICING
TABLE 30. UNITED STATES VIRAL INACTIVATION MARKET: CONTACT DETAILS